# Trade Mark Journal No.2026/027 3 July 2026

## WO0000001922380 (5)

Office of origin: United States of America

Date of International Registration:17 February 2026
Date of designation in the UK: 17 February 2026

International priority date claimed: 19 August 2025 (United States of America) (99345299)

Class 5
  Pharmaceutical compounding kits for veterinary use, namely, kits for compounding pharmaceuticals comprised primarily of pre-weighed, pre-measured pharmaceutical base preparations targeting thyroid disorders, neurological disorders, antimicrobial agents, cardiovascular disorders, gastro-intestinal disorders, treatment of chronic pain and acute pain, and treatment for inflammation.

BridgeHealth Pharmaceuticals, Inc.

Representative: Douglas R. Wolf Wolf Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA